To include your compound in the COVID-19 Resource Center, submit it here.

FDA reviewing Merck’s doravirine for HIV

FDA accepted for review two NDAs from Merck

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE